AltTox Editorial Board and Management Team members at SOT 2016

Home / Community Blog / AltTox Editorial Board and Management Team members at SOT 2016

Community Blog

AltTox Editorial Board and Management Team members at SOT 2016

Contributor: Marilyn Matevia, HSUS

The team will be at the annual Society of Toxicology meeting in New Orleans next week, sharing an informational booth with our site co-sponsor, the Human Toxicology Project Consortium. If you are planning to be there, please stop by booth #1704 to say hello and enter our t-shirt raffle!

A number of the AltTox Management Team and Editorial Board members will be presenting at the conference. Look for these presentations in your conference planner:

  • Kristie Sullivan, “Introduction to Adverse Outcome Pathways and International Activities Guiding AOP Development.” Session: Continuing Education on “Adverse Outcome Pathway (AOP) Development and Evaluation Continuing Education,” Sunday, March 13, 8:15 AM–12:00 PM.
  • Martin Stephens, “Evidence-Based Approaches for Enhancing the Reproducibility of Toxicological Studies.” Session: Scientific Reproducibility: Does This Pose a Problem for 21st Century Toxicology? Monday, March 14, 9:30 AM to 12:15 PM.
  • Bas Blaauboer, “Introduction.” Session: Safety Assessment of Topically Exposed Cosmetic Ingredients: Lessons Learned, Tuesday, March 15, 2:00 PM to 4:45 PM.
  • Grace Patlewicz, “Introduction” and “Do Tox21 Approaches Such as Data from ToxCast Enhance Existing OECD Chemical Categories?” Session: Building Scientific Confidence in the Development and Evaluation of Read- Across for Regulatory Purposes Using Tox21 Approaches, Tuesday, March 15, 2:00 PM to 4:45 PM.
  • William Mundy, “Evaluating the Ability of In Vitro Assays Based on Key Events in Neurodevelopment to Predict Developmental Neurotoxicity (DNT).” Session: Screening Chemicals for Neurotoxicity Outcomes, Wednesday, March 16, 9:30 AM to 12:15 PM.
  • Catherine Willett, “Regulatory Acceptance of Non-standard Toxicological Methods through Increased use of Integrated Approaches to Testing and Assessment (IATA).” Poster Session: Regulation and Policy, Wednesday, March 16, 1:15 PM to 4:45 PM (Abstract #3003/Poster #P143).
  • George Daston, “Selecting Cell Types that Provide Transcriptomic Data Over a Broad Range of Modes of Action.” Session: Which Human Cell Lines Should I Use? Choosing the Appropriate Biological Systems for High-Throughput Toxicity Testing, Thursday, March 17, 9:30 AM to 12:15 PM.
  • Catherine Willett will also give an update on Human Toxicology Project Consortium (HTPC) activities at a satellite meeting co-sponsored by the HTPC, the Center for Alternatives to Animal Testing (CAAT), and the Human Toxome Project Consortium, “Updates on Activities Related to 21st Century Toxicology and Related Efforts: Invited Presentations and Open Microphone,” Thursday, March 17, 12:30 PM–4:00 PM. Martin Stephens will present there, as well, discussing Evidence-Based Toxicology. This satellite meeting will take place at the Hilton New Orleans Riverside. Box lunches will be available for those who have pre-registered; to register, contact Jamie DeRita at CAAT.